{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:31:05Z","timestamp":1790739065223,"version":"4.1.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antimicrobial prescribing in patients approaching end of life is complex. We aimed to describe antimicrobial use in the final 4 weeks of life among hospitalized patients and identify factors associated with antimicrobial consumption.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective review of antimicrobial use among inpatients during their last 4 weeks of life in a tertiary Irish hospital. Data collected included antimicrobial agents and duration of therapy, microbiological sampling, infection services input, palliative care services input, patient demographics, frailty scores, and markers of inflammation. Univariate analysis and multivariable linear regression were used to assess factors associated with antimicrobial-free time before death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Two hundred and fifty-eight patients were included, with 91% receiving antimicrobials during the study period. Only 36% had a presumed infection at the time of admission. Antimicrobial use was characterized by broad-spectrum agents, did not correlate with culture results, and had a median duration (interquartile range) of 10.5 (5\u201318) days. Palliative care consultation (P = .004) and longer length of stay (P &amp;lt; .0001) were associated with a longer antimicrobial-free interval before death. Within the antimicrobial cohort, 26% developed acute kidney injury. Cessation of antimicrobial therapy often occurred late, with 40% of patients receiving antimicrobial therapy within 24\u2005hours of death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There was a high burden of antimicrobial use in patients nearing the end of life, characterized by broad-spectrum, empiric therapy, often continued until hours before death. We recommend expansion of antimicrobial surveillance and collaboration between infection and palliative care services in order to optimize and rationalize antimicrobial prescribing in patients approaching end of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf670","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:02:10Z","timestamp":1761915730000},"source":"Crossref","is-referenced-by-count":4,"title":["Factors Influencing Antimicrobial Choice and Duration During the Last Month of Life in Hospitalized Patients"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2977-8102","authenticated-orcid":false,"given":"Fergal","family":"Howley","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, St James's Hospital , Dublin ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2144-0641","authenticated-orcid":false,"given":"Eva","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, St James's Hospital , Dublin ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciara","family":"Anderson","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St James's Hospital , Dublin ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Fagan","sequence":"additional","affiliation":[{"name":"Department of General Medicine, St James's Hospital , Dublin ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0250-9305","authenticated-orcid":false,"given":"Sam","family":"Grennan","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St James's Hospital , Dublin ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Korn","sequence":"additional","affiliation":[{"name":"Department of Nursing, St James's Hospital , Dublin ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7089-0665","authenticated-orcid":false,"given":"Liam","family":"Townsend","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St James's Hospital , Dublin ,","place":["Ireland"]},{"name":"Department of Clinical Medicine, Trinity College Dublin , Dublin ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciaran","family":"Bannan","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St James's Hospital , Dublin ,","place":["Ireland"]},{"name":"Department of Clinical Medicine, Trinity College Dublin , Dublin ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3982-9882","authenticated-orcid":false,"given":"Aoibheann","family":"Conneely","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, St James's Hospital , Dublin ,","place":["Ireland"]},{"name":"Department of Clinical Medicine, Trinity College Dublin , Dublin ,","place":["Ireland"]},{"name":"Our Lady's Hospice and Care Service , Dublin ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"2025111813364649000_ofaf670-B1","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1093\/cid\/ciad735","article-title":"State-of-the-art review: use of antimicrobials at the end of life","volume":"78","author":"Karlin","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025111813364649000_ofaf670-B2","first-page":"325","article-title":"Antibiotics in palliative medicine\u2014results from a prospective epidemiological investigation from the HOPE survey","volume":"20","author":"Stiel","year":"2012","journal-title":"Support Care Cancer"},{"key":"2025111813364649000_ofaf670-B3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.idh.2018.12.001","article-title":"Antimicrobial use in patients at the end of life in an Australian hospital","volume":"24","author":"Dyer","year":"2019","journal-title":"Infect Dis Health"},{"key":"2025111813364649000_ofaf670-B4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/cancers8090084","article-title":"Antibiotic treatment in end-of-life cancer patients\u2014a retrospective observational study at a palliative care center in Sweden","volume":"8","author":"Helde-Frankling","year":"2016","journal-title":"Cancers (Basel)"},{"key":"2025111813364649000_ofaf670-B5","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1089\/jpm.2013.0276","article-title":"Antimicrobial use for symptom management in patients receiving hospice and palliative care: a systematic review","volume":"16","author":"Rosenberg","year":"2013","journal-title":"J Palliat Med"},{"key":"2025111813364649000_ofaf670-B6","author":"Scottish Antimicrobial Prescribing Group"},{"key":"2025111813364649000_ofaf670-B7","author":"Central Statistics Office"},{"key":"2025111813364649000_ofaf670-B8","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1164\/rccm.200711-1617OC","article-title":"Duration of withdrawal of life support in the intensive care unit and association with family satisfaction","volume":"178","author":"Gerstel","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2025111813364649000_ofaf670-B9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.hrtlng.2024.10.005","article-title":"Time to death after compassionate extubation in medical and neuroscience intensive care units","volume":"69","author":"Chen","year":"2025","journal-title":"Heart Lung"},{"key":"2025111813364649000_ofaf670-B10","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/10499091241282627","article-title":"Antibiotics at end of life: where are we now and where are we going? A narrative review","volume":"42","author":"Crowley","year":"2025","journal-title":"Am J Hosp Palliat Care"},{"key":"2025111813364649000_ofaf670-B11","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1017\/ash.2023.207","article-title":"Frontiers in antimicrobial stewardship: antimicrobial use during end-of-life care","volume":"3","author":"Lee","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"2025111813364649000_ofaf670-B12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijid.2021.10.026","article-title":"End-of-life use of antibiotics: a survey on how doctors decide","volume":"114","author":"Crispim","year":"2022","journal-title":"Int J Infect Dis"},{"key":"2025111813364649000_ofaf670-B13","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2025111813364649000_ofaf670-B14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12904-025-01649-x","article-title":"Current trends in antimicrobial use and the role of antimicrobial stewardship in palliative oncology: a narrative review","volume":"24","author":"Awada","year":"2025","journal-title":"BMC Palliat Care"},{"key":"2025111813364649000_ofaf670-B15","doi-asserted-by":"crossref","first-page":"dlaa071","DOI":"10.1093\/jacamr\/dlaa071","article-title":"Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection","volume":"2","author":"Townsend","year":"2020","journal-title":"JAC Antimicrob Resist"},{"key":"2025111813364649000_ofaf670-B16","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/cid\/ciaa530","article-title":"Bacterial and fungal co-infection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing","volume":"71","author":"Rawson","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025111813364649000_ofaf670-B17","first-page":"e31689","article-title":"Factors that influence the prescription of antibiotic therapy at the end-of-life: construction and validation of a scale","volume":"14","author":"Campoa","year":"2022","journal-title":"Cureus"},{"key":"2025111813364649000_ofaf670-B18","doi-asserted-by":"crossref","first-page":"e0146852","DOI":"10.1371\/journal.pone.0146852","article-title":"Frequent prescription of antibiotics and high burden of antibiotic resistance among deceased patients in general medical wards of acute care hospitals in Korea","volume":"11","author":"Kwak","year":"2016","journal-title":"PLoS One"},{"key":"2025111813364649000_ofaf670-B19","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1089\/jpm.2016.0094","article-title":"Antimicrobial use in patients on a comfort care protocol: a retrospective cohort study","volume":"19","author":"Merel","year":"2016","journal-title":"J Palliat Med"},{"key":"2025111813364649000_ofaf670-B20","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/02692163231162889","article-title":"Antibiotic therapy is associated with adverse drug events among older adults with advanced cancer: a cohort study","volume":"37","author":"Datta","year":"2023","journal-title":"Palliat Med"},{"key":"2025111813364649000_ofaf670-B21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/15360288.2018.1513435","article-title":"Adverse drug reactions in palliative care","volume":"32","author":"O\u2019Leary","year":"2018","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"2025111813364649000_ofaf670-B22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/0897190013499523","article-title":"Antibiotic-associated diarrhea: a refresher on causes and possible prevention with probiotics\u2014continuing education article","volume":"26","author":"Varughese","year":"2013","journal-title":"J Pharm Pract"},{"key":"2025111813364649000_ofaf670-B23","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.3390\/jcm11133923","article-title":"Palliative care for patients with kidney disease","volume":"11","author":"Lanini","year":"2022","journal-title":"J Clin Med"},{"key":"2025111813364649000_ofaf670-B24","doi-asserted-by":"crossref","first-page":"ofac692","DOI":"10.1093\/ofid\/ofac692","article-title":"Perceptions and reality of antimicrobial prescribing during the transition to comfort measures only at an academic medical center","volume":"10","author":"Larnard","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2025111813364649000_ofaf670-B25","doi-asserted-by":"crossref","first-page":"e1004013","DOI":"10.1371\/journal.pmed.1004013","article-title":"Implications of reducing antibiotic treatment duration for antimicrobial resistance in hospital settings: a modelling study and meta-analysis","volume":"20","author":"Mo","year":"2023","journal-title":"PLoS Med"},{"key":"2025111813364649000_ofaf670-B26","doi-asserted-by":"crossref","first-page":"e26578","DOI":"10.1371\/journal.pone.0026578","article-title":"Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms","volume":"6","author":"Totsika","year":"2011","journal-title":"PLoS One"},{"key":"2025111813364649000_ofaf670-B27","doi-asserted-by":"crossref","first-page":"11786329241280812","DOI":"10.1177\/11786329241280812","article-title":"The use of antibiotics at the end of life: a cross-sectional study","volume":"17","author":"Miranda-Chavez","year":"2024","journal-title":"Health Serv Insights"},{"key":"2025111813364649000_ofaf670-B28","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1017\/ash.2024.61","article-title":"Improving shared decision-making around antimicrobial-prescribing during the end-of-life period: a qualitative study of veterans, their support caregivers and their providers","volume":"4","author":"Goedken","year":"2024","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"2025111813364649000_ofaf670-B29","doi-asserted-by":"crossref","first-page":"ofab361","DOI":"10.1093\/ofid\/ofab361","article-title":"Association of physician orders for life-sustaining treatment with inpatient antimicrobial use at end of life in patients with cancer","volume":"8","author":"Kates","year":"2021","journal-title":"Open Forum Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf670\/65099523\/ofaf670.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/11\/ofaf670\/65099523\/ofaf670.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/11\/ofaf670\/65099523\/ofaf670.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T18:36:57Z","timestamp":1763491017000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf670\/8313037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf670","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,10,30]]},"article-number":"ofaf670"}}